ATH 0.00% 0.3¢ alterity therapeutics limited

Not meaning to complain, but the last couple of NASDAQ sessions...

  1. 158 Posts.
    Not meaning to complain, but the last couple of NASDAQ sessions the stock seemed to be begging for an excuse to head strongly north.

    The 11/28 Annual Meeting presentation was a great presentation, but never hit the U.S. newswires under the Pran ticker, so they completely limited the exposure on the strongest statement made to-date on the "physician requested" extension trial.

    I think further, many were expecting an announcement that the last IMAGINE patient dosed has now completed treatment i.e. the IMAGINE trial dosing is completed, given the last patient to be dosed was announced on 11/29/2012. If the AGM was that announcement they certainly never broadcasted it to the U.S. market - not even a whisper.

    So for either of these two things, the market and the chart just seems be begging for the nudge that would take it to the next level. I don't think it would take much at all to send us sharply north. There seems to be alot of pent-up energy in the chart right now, and ample things that management could say for themselves regarding timeline accomplishments related to the trials.

    Just wishful thinking I guess...
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.937K 645.7K

Buyers (Bids)

No. Vol. Price($)
77 96988980 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 655773 2
View Market Depth
Last trade - 10.00am 15/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.